- Home
- Primary Care
- Highlights of the EMERGENT-3 Trial: Advancing Schizophrenia Treatment with Xanomeline-Trospium Chloride

3d3 min read
Medical Article
Introduction Schizophrenia is a chronic psychiatric disorder characterized by positive, negative, and cognitive symptoms, presenting a substantial disease burden and a significant impact on the quality of life and functioning of affected individuals (1). Current antipsychotic therapies predominantly target dopamine D2 receptor antagonism and are as

Highlights of the EMERGENT-3 Trial: Advancing Schizophrenia Treatment with Xanomeline-Trospium Chloride
9 Reached
Similar Content

Male with Urethral Bleeding due to Insertion of Telephone Wire in Urethra
2466 Reached4 Comments6 Likes

Young Girl Presented with Irritability and Abnormal Behavior
2253 Reached10 Comments4 Likes

Management of Infantile Myoclonic Seizures
1169 Reached3 Comments3 Likes

Unconscious Male in ED following Loss of Motorcycle Control
828 Reached2 Comments2 Likes

Headache with Clinically Non-functioning Pituitary Adenoma
818 Reached1 Comments4 Likes